A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma

Carcinogenesis

Volumn 28, Issue 7, 2007, Pages 1430-1436

  Wang, Luo ^a   Wei, Qingyi ^a   Shi, Qiuling ^a   Guo, Zhaosheng ^a   Qiao, Yawei ^a   Spitz, Margaret R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BENZO[A]PYRENE DERIVATIVE; DIMETHYL SULFATE; DNA; LUCIFERASE; NITROSAMINE; PHYTOHEMAGGLUTININ; PLASMID DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CELL ASSAY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; DNA ALKYLATION; DNA DAMAGE; DNA REPAIR; EXCISION REPAIR; FEMALE; HOST CELL; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; TOBACCO;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; ADENOCARCINOMA; ADULT; AGED; ALKYLATING AGENTS; ALKYLATION; BIOLOGICAL ASSAY; CARCINOGENS; CASE-CONTROL STUDIES; CELLS, CULTURED; DNA DAMAGE; DNA REPAIR; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGED; NITROSAMINES; PHYTOHEMAGGLUTININS; PILOT PROJECTS; PLASMIDS; RISK FACTORS; SULFURIC ACID ESTERS;

EID: 34547781791     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm029     Document Type: Article

References (36)

1. Wei,Q. et al. (1996) Reduced DNA repair capacity in lung cancer patients. Cancer Res., 56, 4103-4107.
2. Wei,Q. et al. (1996) Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res., 56, 3975-3979.
3. Li,D. et al. (1996) In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. Cancer Res., 56, 3638-3641.
4. Wynder,E.L. et al. (1995) The changing epidemiology of smoking and lung cancer histology. Environ. Health Perspect., 103 (suppl. 8), 143-148.
5. Hecht,S.S. (1999) DNA adduct formation from tobacco-specific N-nitrosamines. Mutat. Res., 424, 127-142.
6. Ziegel,R. et al. (2003) K-ras gene sequence effects on the formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone(NNK)-DNA adducts. Chem. Res. Toxicol., 16, 541-550.
7. Wei,Q. et al. (1993) DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc. Natl. Acad. Sci. USA, 90 1614-1618.
8. Ahn,B. et al. (2004) Repair of mitomycin C cross-linked DNA in mammalian cells measured by a host cell reactivation assay. Mol. Cells, 18, 249-255.
9. Athas,W.F. et al. (1991) Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Res. 51, 5786-5793.
10. Qiao,Y. et al. (2002) Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutat. Res., 509, 165-174.
11. Schlicker,A. et al. (l999) 4-Amino- 1,8-naphthalimide: A novel inhibitor of poly(ADP-ribose) polymerase and radiation sensitizer. Int. J. Radiat. Biol., 75, 91-100.
12. Wei,Q. et al. (2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: A molecular epidemiologic study. J. Natl Cancer Inst., 92, 1764-1772.
13. Maxam,A.M. et al. (1977) A new method for sequencing DNA. Proc. Natl Acad. Sci. USA, 74, 560-564.
14. Kumar,R. et al. (1996) Separation of 7-methyl- and 7-(2-hydroxyethyl)-guanine adducts in human DNA samples using a combination of TLC and HPLC. Carcinogenesis, 17, 485-492.
15. Sambrook,J. et al. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press. NY.
16. Qiao,Y. et al. (2002) Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis, 23, 295-299.
17. Wei,Q. et al. (2003) Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J. Natl Cancer Inst., 95 308-315.
18. Emmert,S. et al. (2002) Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients. J. Invest. Dermatol., 118, 972-982.
19. Cheng,L. et al. (1996) Fluorescence in situ hybridization method for measuring transfection efficiency. Biotechniques, 21 486-491.
20. Hoffmann,D. et al. (1982) Tobacco specific N-nitrosamines: occurrence and bioassays. IARC Sci. Publ., 41, 309-318.
21. Hoffmann,D. et al. (1994) Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: Chemistry, biochemistry, carcinogenicity, and relevance to humans. J. Toxicol. Environ. Health 41, 1-52.
22. 6-methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung. Cancer Res., 51, 5557-5564.
23. Hecht,S.S. et al. (1993) Tobacco-specific nitrosamine adducts: studies in laboratory animals and humans. Environ. Health Perspect. 99, 57-63.
24. Kraemer,K.H. et al. (1985) Xeroderma pigmentosum. Clin. Dermatol., 3, 33-69.
25. Wei,Q. et al. (1997) The role of DNA repair capacity in susceptibility to lung cancer: A review. Cancer Metastasis Rev., 16, 295-307.
26. Spitz,M.R. et al. (2003) Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol. Biomarkers Prev. 12, 689-698.
27. Shi,Q. et al. (2004) Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis, 25, 1695-1700.
28. Hall,J. et al. (1994) DNA repair capacity as a risk factor for non-melanocytic skin cancer - a molecular epidemiological study. Int. J. Cancer, 58, 179-184.
29. Zang,E.A. et al. (1996) Differences in lung cancer risk between men and women: Examination of the evidence. J. Natl Cancer Inst., 88, 183-192.
30. D'Errico,M. et al. (1999) Factors that influence the DNA repair capacity of normal and skin cancer-affected individuals. Cancer Epidemiol. Biomarkers Prev., 8, 553-559.
31. Dybdahl,M. et al. (1999) Low DNA repair is a risk factor in skin carcinogenesis: A study of basal cell carcinoma in psoriasis patients. Mutat. Res., 433, 15-22.
32. Landi,M.T. et al. (2002) DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma. J. Natl Cancer Inst., 94, 94-101.
33. Matta,J.L. et al. (2003) DNA repair and nonmelanoma skin cancer in Puerto Rican populations. J. Am. Acad. Dermatol., 49, 433-439.
34. Cheng,L. et al. (1998) Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol. Biomarkers Prev., 7, 465-468.
35. Hu,JJ. et al. (2004) Deficient nucleotide excision repair capacity enhances human prostate cancer risk. Cancer Res., 64, 1197-1201.
36. Ramos,J.M. et al. (2004) DNA repair and breast carcinoma susceptibility in women. Cancer, 100, 1352-1357.